Merck to pay $950 million to settle U.S. Vioxx charge

Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday. The fine will conclude ...

Reuters - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

(Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S.

Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the DOJ said on Tuesday.

Merck will pay $950 million to settle criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced.

By The Burrill Report: Merck (MRK) will pay $950 million to settle criminal and civil charges related to the improper promotion and marketing of the painkiller Vioxx. The U.S. Department of Justice say Merck will pay $321.6 million in criminal fines and $628.4 as part of a civil settlement. The company also pleaded guilty to a misdemeanor charge that it marketed Vioxx for off-label use.

Merck will pay $950 million to settle criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced.

Pharmaceutical giant Merck will pay nearly $1 billion to resolve criminal and civil charges for mismarketing the painkiller Vioxx, the US Department of Justice said Tuesday.Merck agreed to plead guilty to one count of breaking the Food Drug and Cosmetic Act and to one criminal misdemeanor, after it promoted Vioxx for rheumatoid arthritis when the drug had not been approved for that disease, a government statement said.